Verily, Alphabet’s life science subsidiary, has shifted its focus to using AI and data science for precision health. Andrew Trister, Verily’s chief medical and science officer, discussed the company’s collaboration with Google, its development of technologies like the Verily Retinal Camera, and its exploration of generative AI models like Med-PaLM and Gemini. Verily aims to improve healthcare outcomes by addressing various pain points in the healthcare system. Trister is excited about Verily’s potential to integrate its technologies holistically, creating mutually reinforcing solutions that could lead to cost reductions and improved health outcomes for individuals.
Source link
Q&A: Verily on using generative AI within healthcare
